Xcout Intel
2cureX
2cureX develops products for individualized therapy selection in oncology, utilizing 3D cell culture technologies to create patient-derived tumor models for drug sensitivity testing. Its IndiTreat technology enables healthcare professionals to evaluate drug responses using 3D microtumors, helping doctors select optimal cancer treatments for individual patients.
Subscribe to see 2cureX’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
2cureX at a glance
2cureX is a health care company headquartered in Sweden. Xcout tracks 8 named people at 2cureX, including Kenneth Graabek Johansen (CFO).
2cureX leadership
- Kenneth Graabek JohansenCFO
- Jacob ThastrupCTO
- Tonni Bülow-NielsenChairman
- Ole ThastrupCEO, Founder and Board member
- Grith HagelVP Innovation, Co-Founder and Board member
- Manuel FernándezQA/RA Director
2 more named people on record for 2cureX, with roles, board committees and tenure — see the full roster →
Get 2cureX's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on 2cureX in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access